Live Breaking News & Updates on Xess Trials

Xeltis Announces Latest Results from aXess Trials to be Presented at 46th Annual Charing Cross Symposium Two key presentations by leading KOLs highlight positive results from aXess trials in adult patients with end-stage renal disease who need vascular access to hemodialysisaXess is a restorative arteriovenous. ....

United States , City Of , United Kingdom , Charing Cross , Alexander Goemans , Joshua Evans , Eliane Schutte , Paulo Neves , Robert Shahverdyan , Nick Bastin , Head Of Vascular Access Center Hamburg , Department Of Vascular Surgery , University Medical Center , Strategic Communications , Davita Venture Group , European Innovation Council , Life Sciences , Pharma Group , Xeltis Announces Latest Results , Xess Trials , Annual Charing Cross , Annual Charing Cross Symposium , Vascular Access Center Hamburg , Prof Dr Frans Moll , Vascular Surgery , Infection Control Prevention ,